期刊文献+

铜绿假单胞菌血流感染27例临床分析 被引量:16

Clinical analysis of bloodstream infections caused by Pseudomonas aeruginosa
在线阅读 下载PDF
导出
摘要 目的探讨铜绿假单胞菌血流感染的临床特点及细菌耐药性。方法回顾性分析北京大学第三医院2006年1月—2009年12月铜绿假单胞菌血流感染患者的临床及微生物学资料。结果 27例患者纳入分析。患者基础疾病评分(Charlson评分)为4.48±2.10;发生血流感染时均有发热、外周血白细胞减少或升高;9例患者发生感染中毒性休克,9例患者住院死亡。患者血流感染来源于下呼吸道感染最多,其次为中心静脉内导管相关感染。发生多重耐药(MDR)菌株感染6例。与非MDR组相比较,MDR组患者入院时的急性生理与慢性健康评估(APACHE)Ⅱ评分和感染相关器官衰竭评分(SOFA评分)显著升高,入住ICU时间显著延长,入院至血培养阳性前接受2类或2类以上抗菌药物治疗比率显著升高,血培养阳性后的适当经验性抗菌药物治疗率显著降低;两组Charlson评分、临床表现、抽取血培养时的APACHEⅡ评分与SOFA评分、住院病死率等差异无统计学意义。结论铜绿假单胞菌血流感染患者病情较重,病死率较高,该菌MDR菌株感染患者入院时病情多重于非MDR感染者,两者临床表现相似,应积极行病原学检查,尽早选用敏感抗菌药物治疗以降低病死率。 Objective To analyze the clinical characteristics and antimicrohial resistance of blood stream infections caused by P. aeruginosa. Methods The clinical data were retrospectively reviewed for the patients with P. aeruginosa bloodstream infection who were treated in Peking University Third Hospital from January 2006 to December 2009. Results A total of 27 patients were found with P. aeruginosa bloodstream infection. The Charlson scores of the patients were 4. 48 ±2.10. All patients had fever and increased or decreased white blood cell counts when their bloodstream infection was identified. Six patients were infected by multidrugresistant (MDR) strains. Compared with the patients with nonMDR P. aeruginosa infection, the patients infected by MDR strains had significantly higher APACHE 11 scores and Sequential Organ Failure Assessment (SOFA) scores at ad mission, longer stay in Intensive Care Unit (RICU and SICU), higher prevalence of multiple (two or more) antibiotics use be fore positive blood culture after admission, and lower proprotion of patients with appropriate antibiotic therapy after blood cul ture. The Charlson scores, clinical manifestation, APACHEⅡ scores and SOFA scores at the time of bloodstream infection, and inhospital mortality were similar between the two groups of patients. Conclusions The patients with P. aeruginosa blood stream infection showed severe clinical status and high mortality rate. The MDR strainsinfected patients had more severe con ditions than those infected by nonMDR strains, but their clinical manifestations were similar. Patients with bloodstream infec tion should subject to microbiological testing and be treated with appropriate active agents as soon as possible to reduce fatality rate.
出处 《中国感染与化疗杂志》 CAS 北大核心 2013年第2期81-85,共5页 Chinese Journal of Infection and Chemotherapy
关键词 铜绿假单胞菌 血流感染 多重耐药 临床表现 P. aeruginosa bloodstream infection multidrug-resistance clinical manifestation
  • 相关文献

参考文献11

  • 1Parkins MD,Gregson DB,Pitout JD, et al. Population-based study of the epidemiology and the risk factors forPseudomonas aeruginosa bloodstream infection [ J]. Infec-tion, 2010,38(1): 25-32.
  • 2Tam VH, Chang KT, Abdelraouf K, et al. Prevalence, re-sistance mechanisms, and susceptibility of muitidrug-resistantbloodstream isolates of Pseudomonas aeruginosa[J] Antimi-crob Agents Chemother, 2010,54(3) : 1160-1164.
  • 3Charlson ME,Pompei P, Ales KL,et al. A new method ofclassifying prognostic comorbidity in longitudinal studies: de-velopment and validation[J], J Chronic Dis, 1987,40(5) :373-383.
  • 4Marra AR, Bearman GM, Wenzel RP, et al. Comparison ofseverity of illness scoring systems for patients with nosocomi-al bloodstream infection due to Pseudomonas aeruginosa [J],BMC Infect Dis, 2006, 6: 132-137.
  • 5Marra AR, Bearman GM, Wenzel RP, et al. Comparison ofthe systemic inflammatory response syndrome between mo-nomicrobial and polymicrobial Pseudomonas aeruginosa noso-comial bloodstream infections[J]. BMC Infect Dis, 2005,5:94-100.
  • 6Suarez C,Pena C. Tubau F,et al. Clinical impact of imipen-em-resistant Pseudomonas aeruginosa bloodstream infections[J]. J Infect, 2009,58(4) :285-290.
  • 7Suarez C,Pena C, Gavalda L, et al. Influence of carbapenemresistance on mortality and the dynamics of mortality inPseudomonas aeruginosa bloodstream infection [J]. Int J In-fect Dis, 2010, 14 Suppl 3:e73-78.
  • 8Kang Cl, Kim SH, Park WB, et al. Risk factors for antimi-crobial resistance and influence of resistance on mortality inpatients with bloodstream infection caused by Pseudomonasaeruginosa [J]. Microb Drug Resist, 2005,11(1):68-72.
  • 9Gomez J, Alcantaram M, Simarro E, et al. Pseudomonasaeruginosa bacteremia: clinical and epidemiological patternsand treatment[J]. Rev Esp Quimioter,2002,15(4) :360-365.
  • 10Joo EJ, Kang Cl, Ha YE, et al. Risk factors for mortality inpatients with Pseudomonas aeruginosa bacteremia: clinicalimpact of antmicrobial resistance on outcome [J]. MicrobDrug Resist, 2011,17(2):305-312.

同被引文献139

引证文献16

二级引证文献177

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部